Synthesis of N4-substituted derivatives of (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (HPMPC, Cidofovir, Vistide®)

被引：0

作者：

Chalupová, D ^{[1
]}

Holy, A ^{[1
]}

机构：

[1] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic

来源：

CHEMISTRY OF NUCLEIC ACID COMPONENTS | 2005年 / 7卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine (HPMPC, Cidofovir, Vistide (R)) has a unique profile among the antiviral agents in that it is active against a much broader spectrum of DNA viruses than any other antiviral agent. The activity spectrum of HPMPC encompasses herpes-, adeno-, polyoma-, papilloma and poxviruses. As the systemic drug Viread (TM) it is used for treatment of cytomegalovirus retinitis in AIDS patients. Based on this unique profile of HPMPC we have investigated the effect of the substitution of the amino function at the position 4 upon the antiviral activity.

引用

页码：387 / 388

页数：2

共 50 条

[31] Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses
Valiaeva, Nadejda
Prichard, Mark N.
Buller, R. Mark
Beadle, James R.
Hartline, Caroll B.
Keith, Kathy A.
Schriewer, Jill
Trahan, Julissa
Hostetler, Karl Y.
ANTIVIRAL RESEARCH, 2009, 84 (03) : 254 - 259
[32] Synthesis and evaluation of octadecyloxyethyl esters of five 3-hydroxy-2-(phosphonomethoxy)propyl nucleoside phosphonates in HIV-1 infected cells
Valiaeva, Nadejda
Aldern, Kathy A.
Trahan, Julissa
Beadle, James R.
Hostetler, Karl Y.
ANTIVIRAL RESEARCH, 2008, 78 (02) : A49 - A50
[33] TREATMENT OF MURINE CYTOMEGALOVIRUS INFECTIONS IN SEVERE COMBINED IMMUNODEFICIENT MICE WITH GANCICLOVIR, (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE, INTERFERON, AND BROPIRIMINE
SMEE, DF
MORRIS, JLB
LEONHARDT, JA
MEAD, JR
HOLY, A
SIDWELL, RW
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 1837 - 1842
[34] MECHANISM OF UPTAKE OF THE PHOSPHONATE ANALOG (S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE (HPMPC) IN VERO CELLS
CONNELLY, MC
ROBBINS, BL
FRIDLAND, A
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (06) : 1053 - 1057
[35] METABOLISM OF 1-(S)-(3-HYDROXY-2-PHOSPHONOMETHOXYPROPYL)-CYTOSINE (HPMPC) IN HUMAN EMBRYONIC LUNG-CELLS
CIHLAR, T
VOTRUBA, I
HORSKA, K
LIBOSKA, R
ROSENBERG, I
HOLY, A
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1992, 57 (03) : 661 - 672
[36] Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents
Krecmerova, Marcela
Holy, Antonin
Andrei, Graciela
Pomeisl, Karel
Tichy, Tomas
Brehova, Peter
Masojidkova, Milena
Dracinsky, Martin
Pohl, Radek
Laflamme, Genevieve
Naesens, Lieve
Hui, Hon
Cihlar, Tomas
Neyts, Johan
De Clercq, Erik
Balzarini, Jan
Snoeck, Robert
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) : 6825 - 6837
[37] Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as Anti-Poxvirus Agents
Krecmerova, Marcela
Holy, Antonin
Andrei, Graciela
Pomeisl, Karel
Tichy, Tomas
Laflamme, Genevieve
Naesens, Lieve
Cihlar, Tomas
Neyts, Johan
De Clercq, Erik
Balzarini, Jan
Snoeck, Robert
ANTIVIRAL RESEARCH, 2010, 86 (01) : A59 - A60
[38] RETINAL TOXICITY OF THE ANTI-CMV DRUG (S)-1-(3-HYDROXY-2-PHOSPHORYLMETHOXYPROPYL) CYTOSINE (S-HPMPC)
DOLNAK, DR
MUNGUIA, D
BERGERONLYNN, GL
WILEY, CA
DECLERCQ, E
BOSCHER, C
CONNOR, JD
FREEMAN, WR
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 883 - 883
[39] SYNTHESIS OF (S)-N1-(3-HYDROXY-2-PHOSPHONYLMETHOXY)PROPYLCYTOSINE, (S)-HPMPC
WEBB, RR
WOS, JA
BRONSON, JJ
MARTIN, JC
TETRAHEDRON LETTERS, 1988, 29 (43) : 5475 - 5478
[40] TREATMENT WITH INTRAVENOUS (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS INFECTION WITH HERPES-SIMPLEX VIRUS IN A PATIENT WITH AIDS
LALEZARI, JP
DREW, WL
GLUTZER, E
MINER, D
SAFRIN, S
OWEN, WF
DAVIDSON, JM
FISHER, PE
JAFFE, HS
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03): : 570 - 572

← 1 2 3 4 5 →